<DOC>
	<DOC>NCT02950467</DOC>
	<brief_summary>The purpose of this study is to determine whether psilocybin-assisted group psychotherapy is a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).</brief_summary>
	<brief_title>Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors</brief_title>
	<detailed_description>This study is an open-label mixed-methods pilot study of an individual oral psilocybin drug session combined with eight sessions of an evidence-based, manualized brief group psychotherapy for existential distress in palliative care patients. This study aims to include at least two therapy groups of at least four members each.</detailed_description>
	<mesh_term>Psilocybine</mesh_term>
	<mesh_term>N,N-Dimethyltryptamine</mesh_term>
	<criteria>Inclusion Criterion: Older gayidentified men who are longterm AIDS survivors and suffer from moderatetosevere demoralization. A physical, neurological or cognitive condition that makes participating in the study unsafe or unfeasible. Regular psychotropic medication use. Personal or family history of serious mental illness. Severe depression requiring immediate standardofcare treatment. Current substance use disorder (other than tobacco). Exclusion by the clinical judgment of the study investigators.</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HIV/AIDS</keyword>
	<keyword>Demoralization</keyword>
	<keyword>Psilocybin</keyword>
	<keyword>Group therapy</keyword>
</DOC>